ICI colitis linked to high rehospitalization, ICU use, and mortality even after therapy discontinuation.
Miguel Regueiro, MD
Advertisement
Miguel Regueiro, MD, Chief of Cleveland Clinic’s Digestive Disease Institute
Articles by Miguel Regueiro, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
3
Choosing Among Approved JAK Inhibitors: Baricitinib, Ritlecitinib, and Deuruxolitinib
4
CX11 Shows Weight Loss in Phase 2 Obesity Trial, Corxel Reports
5